Experts Urge Plan to Define and Measure Blood Unavailability

November 04, 2026

A team of experts in the blood community are proposing a plan to measure patient blood availability. The plan was detailed in a commentary published recently in Transfusion.

The team of experts, which includes former AABB president Meghan Delaney, DO, MPH, said that recent blood shortages, including one in summer 2026, have highlighted the need to quantify how often patients with a clinical indication for blood products “did not receive it in the required type, quantity, condition, place or time.” The authors suggest that while the blood community counts units and detects harm well, “it now needs a third capability: counting the patients whose clinical need for blood was not met.”

The group proposes a plan in four parts, including a “definition of blood unavailability, a minimum dataset that fits within the existing blood-request and issue process, four core indicators, and a practical method for collecting them from a sample of patient charts in hospitals with electronic or paper records.”

The group said that further steps should include professional societies and stakeholder groups convening a “consensus process on the definition, the dataset, and the screening criteria, with explicit representation from settings where the paper-based audit must work.” Next, pilots at sentinel hospitals at differing income levels should be conducted for “a defined period, report data completeness and inter-rater agreement on the reason codes, and publish the results whatever they show.” Lastly, they propose that anonymized aggregate indicators be incorporated into routine national reporting and eventually into the Global Database on Blood Safety.